Chicago Equity Partners’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
BG
TS
SCM
Chicago Equity Partners's HALO Position: Q1 2020 in Review
Chicago Equity Partners increased its Halozyme (HALO) stake by 72% in Q1 2020, buying an estimated $778K and bringing the position to 98,120 shares worth $1.76M. The position accounts for 0.18% of the portfolio, ranked #162.
Chicago Equity Partners first reported a position in HALO in Q4 2013 and has held it in 17 quarters since. The position peaked at $4.63M in Q4 2017. 209 funds tracked by Wall St. Rank hold HALO as of Q1 2020.
- Chicago Equity Partners held 98,120 shares of Halozyme worth $1.76M as of Q1 2020.
- Chicago Equity Partners bought 40,995 Halozyme shares in Q1 2020, an estimated $778K.
- Halozyme made up 0.18% of Chicago Equity Partners's portfolio in Q1 2020, its #162 holding.
- Chicago Equity Partners first reported a position in Halozyme in Q4 2013 and has held it in 17 quarters since.
- Chicago Equity Partners's Halozyme position peaked at $4.63M in Q4 2017.
- 209 funds tracked by Wall St. Rank held Halozyme as of Q1 2020.
Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.